A leading multidisciplinary think tank, the PHG Foundation, will become part of the University of Cambridge from 1 April this year, with a focus on making science work for health. This has been made possible by a philanthropic gift from the Hong Kong-based Hatton Trust, which has recognised the University’s global eminence in science, medicine and the humanities alongside the pioneering policy development work of the Foundation.
A new collaboration between the University of Cambridge, Papworth Hospital NHS Foundation Trust and Sunway Medical Centre in Malaysia will see researchers and clinicians from the two countries working together across borders and disciplinary divides to tackle some of the world’s major health challenges.
GSK, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust today announce their Strategic Partnership, with the long-term ambition to jointly deliver new medicine to patients in the next 5-10 years.
One of the world’s leading childhood brain tumour experts, Professor Richard Gilbertson, has been appointed as Li Ka Shing Chair of Oncology in Cambridge and Director of the Cambridge Cancer Centre. He will take up his appointment in August.
A partnership led by the Medical Research Council (MRC) has awarded the University of Cambridge £25 million to provide cutting-edge equipment and infrastructure for its clinical research, from imaging single disease cells through to improved targeting of treatments for patients.
AstraZeneca, its global biologics research and development arm, MedImmune, and the University of Cambridge today announce four new collaborations, building on their existing partnership. The latest collaborations reinforce AstraZeneca’s commitment to research in Cambridge following the company’s decision to locate one of its three global R&D centres and its global headquarters in the city that has been home to MedImmune’s biologics research laboratories for 25 years.
A University of Cambridge cancer research laboratory which uses imaging technologies to measure key biologic changes within growing tumours has announced a three-year oncology research collaboration with Medimmune.